Modulation of chemosensitivity in human colon carcinoma cells by downregulating Protein Kinase Cα expression

Journal of Experimental Therapeutics and Oncology

Volumn 1, Issue 4, 1996, Pages 218-221

  Chakrabarty, Subhas ^a   Huang, Shuang ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Chemosensitivity; Colon carcinomas; Protein Kinase C

Indexed keywords

COMPLEMENTARY RNA; ISOENZYME; PRKCA PROTEIN, HUMAN; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; RNA;

ARTICLE; BIOSYNTHESIS; CARCINOMA; CELL CULTURE; COLON TUMOR; DOWN REGULATION; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; IMMUNOBLOTTING; PATHOLOGY; PHYSIOLOGY;

CARCINOMA; COLONIC NEOPLASMS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENETIC VECTORS; HUMANS; IMMUNOBLOTTING; ISOENZYMES; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RNA, ANTISENSE; RNA, NEOPLASM; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030177190     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693-698, 1984.
2. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
3. Coussens L, Parker PJ, Rhee X, et al. Multiple distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways, Science 233: 859-866, 1986.
4. Ahmad S, Trepel JB, Ohno S, Suzuki K, Tsuruo T, Glazer RI. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubin. Mol Pharm 42: 1004-1009, 1992.
5. Blobe GC, Sachs CW, Khan WA, et al. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. J Biol Chem 268: 658-664, 1993.
6. Basu A. The potential of protein kinase C as a target for anticancer treatment. Pharmac Ther 59: 257-280, 1993.
7. Ahmad S, Ahmad RS, Glazer RI. Modulation of P-glycoprotein by protein kinase Cα in a baculovirus expression system. Biochem 33: 10313-10318, 1994.
8. O'Brian CA, Fan D, Ward NE, et al. Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells. Biochem Pharmacol 41: 797-806, 1991.
9. Chakrabarty S. The role of protein kinase C in transforming growth factorβ1 induction of carcinoembryonic antigen in human colon carcinoma cells. J Cellular Physiol 152: 494-499, 1992.
10. Chakrabarty S, Huang S. Role of protein kinase Cα in the induction of carcinoembryonic antigen by transforming growth factorβ1. J Cell Physiol 164: 148-153, 1995.
11. Huang H, Trujillo JM, Chakrabarty S. Proliferation of human colon cells: role of epidermal growth factor and transforming growth factorα. Int J Cancer 52: 978-986, 1992.
12. Huang S, Chakrabarty S. Regulation of fibronectin and laminin receptor expression, fibronectin and laminin secretion in human colon cancer cells by transforming growth factorβ1. Int J Cancer 57: 742-746, 1994.
13. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell, JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
14. Rubinstein LV, Shoemaker RH, Paull KD, et al. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 82: 1113-1118, 1990.
15. Moscow JA, Cowan KH. Multidrug resistance. J Natl Cancer Inst 80: 14-20, 1988.
16. Spoelstra EC, Dekker H, Schuurhuis GJ, Broxterman HJ, Lankelma J. P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport. Biochem Pharmacol 41: 349-359, 1991.